Dr. David Glen Coffey, MD

Dr. Coffey practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Coffey's NPI, 1275775934, was assigned on March 27, 2009. Dr. Coffey graduated from University of Colorado Anschutz Medical Campus in 2009. Dr. Coffey's Washington license number on file is MD60276078.

Dr. Coffey's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Coffey's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coffey practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Coffey's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Coffey is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Coffey's licenses on file in 3 states: Washington, Florida and Colorado.

Dmand AI lists lymphoma and multiple myeloma among the conditions Dr. Coffey treats.

CMS data shows 129 Medicare services from Dr. Coffey across 2 procedure codes in 2024, for 24 Medicare patients. Medicare paid $12,209 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Dr. Coffey in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Coffey's median patient age at 70, with 32% women.

In 2021, Dr. Coffey wrote 82 Medicare Part D claims. They cover 4 drugs, with $1,027,962 in total drug cost. In 2020, CMS named 134 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Coffey for performance year 2024, reported as part of a group. Dr. Coffey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 57 papers to Dr. Coffey, published from 2008 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Lenalidomide. Dr. Coffey has published most often in Blood Adv. Dr. Coffey's most frequent co-authors are Damian J. Green, MD, Francesco Maura, MD and Andrew John Cowan, MD.

CMS Open Payments shows 9 general payments to Dr. Coffey from 7 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $334.

Dr. Coffey graduated from University of Colorado Anschutz Medical Campus in 2009. Dr. Coffey is a member of ASH and Society for Immunotherapy of Cancer.

Dr. Coffey is in network with 12 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.